Caribou Biosciences Stock Forecast

CRBU's stock price has decreased by -81.5% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 6 analysts polled by S&P Global, Caribou Biosciences stock has a consensus rating of "Buy" and an average price target of $5.75. The average 1-year stock price forecast is 1,148.10% higher than the current stock price, while the lowest is $1.00 (+117.06%) and the highest is $13 (+2,721.79%).

Price Target: $5.75 (+1,148.10%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$1.00	$5.75	$4.50	$13
Change	+117.06%	+1148.1%	+876.77%	+2721.8%

Analyst Ratings

The average analyst rating for Caribou Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Oct '26
Strong Buy	7	6	6	6	6	2
Buy	1	1	1	1	1	0
Hold	0	0	0	0	0	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	7	7	7	7	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns H.C. Wainwright	H.C. Wainwright	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Oct 8, 2026
Daina Graybosch Leerink Partners	Leerink Partners	Hold Downgrades $4 → $1	Hold	Downgrades	$4 → $1	+117.06%	Oct 7, 2026
Luca Issi RBC Capital	RBC Capital	Hold Downgrades $10 → $1	Hold	Downgrades	$10 → $1	+117.06%	Oct 7, 2026
Leah R. Cann Brookline Capital Markets	Brookline Capital Markets	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Oct 6, 2026
Alec Stranahan Bank of America Securities	Bank of America Securities	Buy Maintains $6 → $5	Buy	Maintains	$6 → $5	+985.30%	Aug 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

27.38M

from 11.16M

145.34%

from 11.16M

Revenue Next Year

26.74M

from 27.38M

-2.34%

from 27.38M

EPS This Year

-1.04

EPS Next Year

-1.19

from -1.04

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	9.60M	13.85M	34.48M	9.99M	11.16M	27.38M
Revenue Growth	-22.35%	44.31%	148.91%	-71.01%	11.66%	145.34%
Operating Income	-66.98M	-106.40M	-116.06M	-166.62M	-133.92M	-104.07M
Net Income	-66.92M	-99.42M	-102.07M	-149.11M	-148.13M	-99.32M
EPS	-	-	-	-	-	-1.04
Free Cash Flow	-	-	-	-	-112.35M	-114.00M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	100.0M
Avg	27.4M
Low	3.9M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	796.1%
Avg	145.3%
Low	-65.1%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.94
Avg	-1.04
Low	-1.10

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-